Evidence map›Paper›PMID 17148567›Full record

Trial reportThe Journal of clinical endocrinology and metabolism2007

Soy isoflavones do not affect bone resorption in postmenopausal women: a dose-response study using a novel approach with 41Ca.

J M K Cheong, B R Martin, G S Jackson, D Elmore, G P McCabe, J R Nolan, S Barnes, M Peacock, C M Weaver

Open access · bronzeAbstract readRandomized Controlled Trial
In one paragraph

Trial report in The Journal of clinical endocrinology and metabolism, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 2 pooled it
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 2 syntheses or guidelines pooled it, 56 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Isoflavones.Molecules (Basel, Switzerland) · 2019
    Review
  9. Review
  10. A Bayesian approach to an interlaboratory comparison.Chemometrics and intelligent laboratory systems : an international journal sponsored by the Chemometrics Society · 2015
    Article
  11. Article
  12. Ultra-trace analysis ofNuclear instruments & methods in physics research. Section B, Beam interactions with materials and atoms · 2013
    Article
  13. Calcium isolation from large-volume human urine samples for 41Ca analysis by accelerator mass spectrometry.Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine · 2013
    Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Bone-seeking labels as markers for bone turnover: validation of urinary excretion in rats.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2011
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

J M K CheongFoods and Nutrition, Purdue University, 700 West State Street, West Lafayette, Indiana 47907-2059, USA.
B R Martin
G S Jackson
D Elmore
G P McCabe
J R Nolan
S Barnes
M Peacock
C M Weaver
Purdue University West Lafayette · USIndiana University – Purdue University Indianapolis · USUniversity of Alabama at Birmingham · US

Funding

PROJECT 4 - POLYPHENOLS AND DAMAGE IN THE EYEP50AT000477 · NCCIH · PURDUE UNIVERSITY WEST LAFAYETTE · PI WEAVER, CONNIE MARIE · 2000 to 2010
$15.0M
NCCIH NIH HHS P50 AT000477NCCIH NIH HHS P50 AT00477NCRR NIH HHS M01-RR-750
6 · The paper itself

Abstract

introductionThe purpose of this 3-way crossover study was to identify the effective dose of soy protein isolate enriched with isoflavones for suppressing bone resorption in postmenopausal women using a novel, rapid assessment of antibone resorbing treatments.

methodsThirteen postmenopausal women (>or=6 yr since menopause) were predosed with 41Ca iv. After a 200-d baseline period, subjects were given 43 g soy protein/d that contained 0, 97.5, or 135.5 mg total isoflavones in randomized order. The soy protein isolate powder was incorporated into baked products and beverages. Each 50-d intervention phase was preceded by a 50-d pretreatment phase for comparison. Serum isoflavone levels and biochemical markers were measured at the end of each phase. Twenty-four-hour urine samples were collected approximately every 10 d during each phase for 41Ca/Ca analysis by accelerator mass spectrometry.

resultsSerum isoflavone levels reflected the amount of isoflavones consumed in a dose-dependent manner. None of the isoflavone levels had a significant effect on biochemical markers of bone turnover, urinary cross-linked N teleopeptides of type I collagen and serum osteocalcin, or bone turnover as assessed by urinary 41Ca/Ca ratios.

conclusionsSoy protein with isoflavone doses of up to 135.5 mg/d did not suppress bone resorption in postmenopausal women. This is the first efficacy trial using the novel technique of urinary 41Ca excretion from prelabeled bone.

Indexed as

PhytotherapyAdultBone and BonesBone ResorptionCalciumCalcium RadioisotopesCollagen Type ICross-Over StudiesDouble-Blind MethodFemaleHumansIsoflavonesMiddle AgedOsteocalcinPeptidesPostmenopauseCalciumCalcium RadioisotopesCollagen Type Icollagen type I trimeric cross-linked peptideIsoflavonesOsteocalcinPeptidesSoybean Proteins

Identifiers

PMID17148567
PMCPMC2683971
OpenAlexW2095571684

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.